EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Pregnancy Outcomes in Grand Multiparity Women With Antiphospholipid Antibodies

Keren Zloto iD, Shani Steinberg, Shir Lev, Rakefet Yoeli-Ullman, Stanley Niznik, Nancy Agmon-Levin, Keren Ofir

American Journal of Reproductive Immunology · 2024

DOI: 10.1111/aji.70013 ↗

Kurz gefasst

Fachartikel in der Zeitschrift American Journal of Reproductive Immunology, 2024. Verfasst von Keren Zloto und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel. Hauptthemen laut MEDLINE: Antibodies, Antiphospholipid, Pregnancy Outcome, Antiphospholipid Syndrome, Parity. Die Arbeit nennt 29 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective In recent years antiphospholipid syndrome (APS) as well as antiphospholipid antibodies (aPL) prevalence has demonstrated an upward trend in women during reproductive age. There is a lack of data concerning its effects on women with grand multiparity (GMP) (parity ≥5). Hence, this study aimed to assess pregnancy outcomes among GMP aPL/APS patients. Study Design We retrospectively assembled the births of GMP women with aPL/APS, between 2017 and 2022 in the Sheba Medical Center. We compared their deliveries with those of two control groups: (1) the “aPL/APS‐controls”—of pregnant women with aPL/APS and parity

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, AntiphospholipidPregnancy OutcomeAntiphospholipid SyndromeParityHumansFemalePregnancyAdultRetrospective StudiesPregnancy ComplicationsInfant, Newborn

Stichwörter der Autor:innen

antiphospholipid syndromegrand multiparitypregnancy outcome

Substanzen

Antibodies, Antiphospholipid

Autor:innen und Institutionen

  • Department of Obstetrics and Gynecology, Sheba Medical Center, Tel-Hashomer, Israel.
  • Faculty of Medical and Health Sciences, School of Medicine, Tel-Aviv University, Tel-Aviv, Israel.
  • Clinical Immunology, Angioedema and Allergy Department, The Zabludowicz Center for Autoimmune Diseases, Sheba Medical Center, Ramat Gan, Israel.

ORCID-Profile: Keren Zloto

Zitieren

APA

Zloto, K., Steinberg, S., Lev, S., Yoeli-Ullman, R., Niznik, S., Agmon-Levin, N., & Ofir, K. (2024). Pregnancy Outcomes in Grand Multiparity Women With Antiphospholipid Antibodies. American Journal of Reproductive Immunology. https://doi.org/10.1111/aji.70013

Vancouver

Zloto K, Steinberg S, Lev S, Yoeli-Ullman R, Niznik S, Agmon-Levin N, et al. Pregnancy Outcomes in Grand Multiparity Women With Antiphospholipid Antibodies. American Journal of Reproductive Immunology. 2024. doi:10.1111/aji.70013

BibTeX
@article{Zloto2024,
  author = {Zloto, Keren and Steinberg, Shani and Lev, Shir and Yoeli-Ullman, Rakefet and Niznik, Stanley and Agmon-Levin, Nancy and Ofir, Keren},
  title = {Pregnancy Outcomes in Grand Multiparity Women With Antiphospholipid Antibodies},
  journal = {American Journal of Reproductive Immunology},
  year = {2024},
  doi = {10.1111/aji.70013}
}
Kostenlos starten →